Follow Us      

LOGIN
 
Share Page:
Back

Volume 23 , Issue 4
July/August 2003

Pages 345-351


Four-Year Results Following Treatment of Intrabony Periodontal Defects with an Enamel Matrix Protein Derivative: A Report of 46 Cases

Anton Sculean, DMD, Dr Med Dent, MS/Giovanni Carlo Chiantella, DDS, MS/Asta Miliauskaite, DDS/Michel Brecx, DDS, Dr Med Dent, Lic Odont, PhD/Nicole Birgit Arweiler, DDS, Dr Med Dent


PMID: 12956478
DOI: 10.11607/prd.00.0537

Treatment of intrabony periodontal defects with an enamel matrix derivative (EMD) has been shown to predictably enhance periodontal regeneration. The aim of the present study was to evaluate the 4-year results following treatment of intrabony defects with EMD. Thirty-three patients with a total of 46 intrabony defects were treated. Each patient exhibited at least one intrabony defect with a probing depth 6 mm as identified by probing and on radiographs. The following clinical parameters were evaluated prior to and 1 and 4 years after treatment: probing depth, recession of the gingival margin, and clinical attachment level. The primary oucome variable was clinical attachment. Mean probing depth was reduced from 8.1 1.8 mm to 3.8 1.2 mm at 1 year and to 4.0 1.2 mm at 4 years. No statistically significant differences were found between the mean probing depth 1 and 4 years postoperative. At 1 year, the mean recession increased from 1.9 1.5 mm to 3.2 1.8 mm; at 4 years, it was 2.8 1.2 mm, a statistically significant improvement compared to the 1-year results, but still significantly increased compared to the baseline. The mean attachment level changed from 10.0 2.4 mm to 7.0 2.1 mm at 1 year and 6.8 1.9 mm at 4 years (no statistically significant difference). The clinical improvements obtained following treatment with EMD can be maintained over a 4-year period. (Int J Periodontics Restorative Dent 2003;23:345C351.)


Full Text PDF File | Order Article

 

 
Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.

 

© 2014 Quintessence Publishing Co, Inc

PRD Home
Current Issue
Ahead of Print
Archive
Author Guidelines
About
Accepted Manuscripts
Submission Form
Submit
Reprints
Permission
Advertising
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us
Help